Document and Entity Information
Document and Entity Information | Dec. 14, 2023 |
Document And Entity Information [Line Items] | |
Entity Registrant Name | PFIZER INC |
Amendment Flag | true |
Entity Central Index Key | 0000078003 |
Document Type | 8-K/A |
Document Period End Date | Dec. 14, 2023 |
Entity Incorporation State Country Code | DE |
Entity File Number | 1-3619 |
Entity Tax Identification Number | 13-5315170 |
Entity Address, Address Line One | 66 Hudson Boulevard East |
Entity Address, Postal Zip Code | 10001-2192 |
Entity Address, City or Town | New York |
Entity Address, State or Province | NY |
City Area Code | (212) |
Local Phone Number | 733-2323 |
Written Communications | false |
Soliciting Material | false |
Pre Commencement Tender Offer | false |
Pre Commencement Issuer Tender Offer | false |
Entity Emerging Growth Company | false |
Amendment Description | On December 14, 2023, Pfizer Inc. filed a Current Report on Form 8-K with Items 2.01, 7.01 and 9.01 (the “Original Report”). Due to a clerical error, the submission header coding in the Original Report inadvertently referred to Item 2.02 on EDGAR and not to Item 2.01. This Amendment No. 1 on Form 8-K/A is being filed for the sole purpose of correcting the submission header coding to refer to Items 2.01, 7.01 and 9.01. All disclosures contained in the Original Report remain unchanged. |
Common Stock [Member] | |
Document And Entity Information [Line Items] | |
Security 12b Title | Common Stock, $0.05 par value |
Trading Symbol | PFE |
Security Exchange Name | NYSE |
Deferrable Notes [Member] | |
Document And Entity Information [Line Items] | |
Security 12b Title | 1.000% Notes due 2027 |
Trading Symbol | PFE27 |
Security Exchange Name | NYSE |